1. Neoadjuvant chemotherapy - residual invasive cancer in the axillary node after chemotherapy, defined as at least microscopic residual disease (>0.2mm) by histology, OR One Step Nucleic acid Amplification (OSNA) macroscopic, OR OSNA microscopic with residual invasive cancer in the breast.